brief communications nature methods | VOL.7 NO.12 | DECEMBER 2010 | 973 been developed that achieves fast temporal and subcellular spatial resolution without the need for exogenous cofactors.
dimerizers allowing inducible control of protein-protein interactions are powerful tools for manipulating biological processes. here we describe genetically encoded light-inducible protein-interaction modules based on Arabidopsis thaliana cryptochrome 2 and cib1 that require no exogenous ligands and dimerize on blue-light exposure with subsecond time resolution and subcellular spatial resolution. We demonstrate the utility of this system by inducing protein translocation, transcription and cre recombinase-mediated dna recombination using light.
Chemical inducers of protein dimerization 1 have been extensively used to modulate protein-protein interactions in live cells, allowing inducible control of signal transduction pathways, transcription and other diverse processes 2 . Although these tools have opened new avenues in experimental biology, chemicals lack tissue specificity, have temporal resolution that is limited by the time required for cell permeation and can be difficult or expensive to deliver to organisms for in vivo studies.
Recently developed genetically encoded dimerizers based on plant photoreceptors allow control of protein-protein interactions by light [3] [4] [5] [6] [7] . One such system 4 is based on Arabidopsis thaliana phytochrome B and PIF6, which associate upon illumination with red light and dissociate upon illumination with far-red light 8 . Although this system offers rapid stimulation and reversibility, the interaction requires a bilin cofactor found only in plants and some light-sensing lower organisms, making use of this system in other organisms challenging because the cofactor must be added exogenously. Another system, using the Arabidopsis light oxygen voltage (LOV) domain protein FKF1 and its interacting partner protein GIGANTEA, requires no exogenous chromophore, but the kinetics of light-triggered dimerization are slow, requiring tens of minutes 5 . Additionally, FKF1 and GIGANTEA remain associated for hours after light exposure, rendering the interaction effectively irreversible. To our knowledge, at present no single optical system for induction of protein interactions has 
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To test the CRY2-CIB1 interaction in mammalian cells, we expressed full-length CRY2 or CRY2PHR fused to monomeric (m)Cherry (CRY2-mCh or CRY2PHR-mCh) together with CIBN fused to a prenylated version of enhanced GFP (EGFP) that localizes to the plasma membrane (CIBN-pmEGFP) ( Fig. 2a) . Initial experiments revealed nuclear localization of CRY2-mCh and CIBN-pmEGFP but cytosolic localization for CRY2PHR-mCh. We mutated predicted nuclear localization signal residues in CRY2-mCh and CIBN-pmEGFP ( Supplementary Fig. 1 ), which resulted in robust cytoplasmic and plasma-membrane expression, respectively, when cells were maintained in the dark (Fig. 2b) . We also generated a nuclear localization signal-deleted version of full-length CIB1 but did not use it because it showed punctate perinuclear localization (data not shown).
We tested the ability of blue light to induce interaction between CRY2-mCh and membrane-associated CIBN-pmEGFP. Within 300 ms after blue-light illumination (488 nm), CRY2-mCh began accumulating at the plasma membrane, where it localized with CIBN-pmEGFP (Fig. 2b,c and Supplementary Video 1). Greater than 95% of cells exhibited robust translocation of CRY2-mCh to the plasma membrane, but the distribution of CIBN-pmEGFP did not change after illumination. Translocation was more than 90% complete within 10 s ( Fig. 2d) . Dim room light (5.2 μW) did not trigger translocation, indicating that samples do not require excessive light shielding. CRY2-mCh and CRY2PHR-mCh had similar activation and reversal kinetics ( Supplementary Fig. 2a ). The complete time course of plasma membrane association and dissociation for the CRY2PHR-CIBN interaction is shown in Figure 2e . After an initial pulse of light, CRY2PHR-mCh rapidly translocated to the plasma membrane and then slowly dissociated over ~12 min. A subsequent light pulse triggered a second round of translocation nearly identical in magnitude to the first ( Fig. 2e) , and we could repeatedly induce the interaction at least six times with little or no loss in efficacy ( Supplementary  Fig. 2b ). Whereas blue light penetrates tissue poorly, multiphoton excitation can allow precise three-dimensional cell targeting in tissues with high cell densities. We found that the CRY-CIB modules could be activated by two-photon stimulation at 860 nm (range, 820-980 nm) in cell culture and organotypic cultured hippocampal slices ( Supplementary Fig. 3 ), suggesting the potential for precise spatial activation of protein dimerization in whole organisms.
One powerful application of artificial dimerizers is to allow inducible control of a 'split' protein, in which two inactive fragments are brought together to reconstitute a functional protein activity. In principle, using this approach with optically controlled dimerizers would confer light-dependent activity to a diverse range of target proteins. We used the CRY-CIB modules to reconstitute split versions of two proteins, a Gal4 transcription factor and Cre recombinase. Based on the transient nature of the CRY-CIB interaction ( Fig. 2e) , we speculated that light pulses would allow precise, dose-dependent control of protein activity. We expressed in yeast the split Gal4 partners Gal4BD-CRY2 and Gal4AD-CIB1 together with a reporter protein (Snl1) under control of a galactose-inducible promoter ( Fig. 3a) . We incubated the yeast in the dark or subjected them to up to twenty blue-light pulses over 4 h (10-s pulses, 8 min apart; Fig. 3b ). Immunoblot analysis of Snl1 revealed a strong dose dependence of protein expression in response to light.
We tested the ability of the CRY-CIB modules to induce dimerization of a split Cre recombinase, allowing light-dependent control of DNA recombination. Based on a previous split Cre recombinase activated by rapamycin 10 , we fused CRY2 to amino acids 19-104 of Cre recombinase (CRY2-CreN), and CIBN to amino acids 106-343 of Cre recombinase (CIBN-CreC) (Fig. 3c) . The Cre modules showed no toxicity in cells (Supplementary Table 1 ). As a reporter of Cre recombinase activity, we used a plasmid containing a transcriptional stop sequence flanked by loxP sites preceding EGFP. When transfected into HEK293T cells, the reporter construct alone displayed low levels of recombination (0.6% ± 0.4% (s.d.) of transfected cells) ( Fig. 3d) , as did control cells expressing either CIBN-CreC or CRY2-CreN alone (data not shown). Cells containing both CRY2-CreN and CIBN-CreC incubated in the dark showed equivalent levels of recombination as control cells (0.7 % ± 0.4% of transfected cells), indicating minimal or no light-independent CRY2-CIBN interaction. Cells containing CRY2-CreN and CIBN-CreC exposed to continuously pulsed blue light for 24 h (2-s pulses every 3 min) showed a 158-fold increase in the number of EGFPexpressing cells (16.4 ± 1.6% of transfected cells) compared to samples incubated in the dark, indicating robust light-dependent activation that was comparable to rapamycin-mediated activation of split Cre recombinase under similar transient transfection conditions 10 (Fig. 3d,e ). Notably, cells exposed to pulsed light for shorter amounts of time, mimicking activation of Cre in a tissue or in vivo, showed a substantial increase in activity over samples incubated in the dark. Exposure to light pulses for only 15 min resulted in a 25-fold increase in EGFP-positive cells over the amount in unexposed samples (3.5 ± 1.3% of transfected cells), and exposure to pulses for 1 h resulted in a ~50-fold increase over the amount in unexposed samples (5.1 ± 1.1% of transfected cells). We expect that optimization of these constructs, such as linker modification and mutagenesis, may allow even more robust light-dependent activation in future iterations. Future improvements to the CRY-CIB modules will include establishment of minimal domains for efficient packaging in viral vectors as well as engineering modules with altered dissociation kinetics and spectral sensitivities. As CRY1 has been observed to dimerize 11, 12 , we are also engineering monomeric versions. As this platform is entirely genetically encoded and can be activated using commonly available light sources, we expect these modules to be useful for controlling a broad range of biological phenomena. MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,  LYS2<GAL1 UAS -GAL1 TATA -HIS3, GAL2 UAS -GAL2 TATA -ADE2,  URA3<MEL1 UAS -MEL1 TATA -lacZ, MEL1) and Y187 (MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112 , gal4Δ, gal80Δ, met-, URA3<GAL1 UAS -GAL1 TATA -lacZ, MEL1) were used (Clontech). The light-inducible transcription study used yeast strain PJ69-4a (MATa trp1-901 leu2-3,112, ura3-52, his3-200, gal4Δ, gal80Δ , LYS2<GAL1-HIS3, GAL2-ADE2, met2<GAL7-lacZ).
Plasmids used in this study are described in Supplementary  Table 2 and will be available from Addgene. Oligonucleotides are listed in Supplementary Table 2 . Gal4 binding domain fusions (Gal4BD-X) were in pDBTrp, a version of pDBLeu (Invitrogen) with a (TRP1) selection marker. Genes encoding Gal4 activation domain fusion proteins (Gal4AD-Y) were in pGADT7rec (Clontech). To generate Gal4BD and Gal4AD constructs, genes encoding Cry2 and Cib1 were PCR-amplified from Arabidopsis thaliana cDNA using gene-specific primers. PCR products from this amplification were then used as template for a second round of PCR using oligos designed to result in expression (after homologous recombination in yeast) of full-length CRY2 or CRY2PHR at the C terminus of Gal4BD, or full-length CIB1 or CIBN (amino acids 1-170) at the C terminus of Gal4AD.
For expression in mammalian cell lines, sequences encoding full-length Cry2 and amino acids 1-498 of Cry2 were PCRamplified and ligated into vector pmCherry-N1 (Clontech) at XhoI and XmaI sites. Sequence encoding CibN was cloned in a similar manner using NheI and AgeI sites into a version of pEGFP-C1 (Clontech) that contained sequence encoding a CaaX polybasic sequence from KRas4B (KKKKKKSKTKCVIM) at the C terminus. To mutate the nuclear localization signal (NLS) sequences, we used oligos CRY2dNLSf and CRY2dNLSr for CRY2 and CIBdNLSf and CIBdNLSr for CIB1. PCR amplification was carried out using mutagenic oligos, and forward and reverse oligos from two-hybrid cloning to generate two overlapping fragments of DNA, which were joined via homologous recombination in yeast. Constructs were tested for interaction in yeast, then moved to mammalian vector systems.
The Cre recombinase constructs were first assembled in yeast (in vector p414ADH) via homologous recombination of two overlapping fragments that had been generated by PCR. For the CRY2-CreN construct, the first fragment contained (in order) 33 bp of homology to p414ADH, a SacI site, a Kozak sequence, sequence encoding full-length (plus NLS) CRY2 and sequence encoding a flexible linker (GGGGSGGGGSGG). The second PCR fragment contained the flexible linker, a NotI site, sequence encoding amino acids 19-104 of Cre recombinase, a stop codon and an XmaI site followed by 33 base pairs of homology to the yeast vector. The CIBN-CreC construct was assembled identically, except sequence encoding CIBN was used in place of that encoding CRY2, and sequence encoding amino acids 106-343 of Cre was used in place of that encoding amino acids 19-104. After recombination in yeast, inserts containing sequences encoding fusion proteins were cut out of p414ADH using SacI and XmaI, and cloned into the multiple cloning site (between SacI and XmaI sites) of pmCherryC1, downstream from an IRES2 element that was placed between mCherry and the multiple cloning site.
Yeast two-hybrid experiments. Gal4BD plasmids containing vector only, or sequence encoding CRY2 or CRY2PHR, were expressed in strain AH109 and patched on YPD plates. On top of patches, Y187 yeast expressing Gal4AD fusions with CIB1, CIBN or yeast containing the empty vector control were patched. Yeast were mated overnight at 30 °C, then streaked on SD plates lacking tryptophan and leucine (SD -Trp, -Leu) to select for diploid cells that contained both Gal4AD and Gal4BD plasmids. Colonies that grew were then streaked on SD -Trp, -Leu, -His plates containing 3 mM 3-aminotriazole (3-AT). β-galactosidase assays were performed by growing yeast cells overnight in -Trp, -Leu medium, followed by dilution to an optical density (OD 600 ) of 0.2 in SD -Trp, -Leu medium the next morning. After an initial 3-h growth period in the dark, cultures were either kept in the dark or continuously exposed to an LED blue light source (461 nm, 1.9 mW) for 4 h. At the conclusion of the 4-h period, cultures were collected and lysed with Y-PER reagent (Thermo Scientific). The assay for β-galactosidase activity was then carried out following a standard protocol for liquid cultures (Clontech; protocol PT3024-1) using ONPG (Sigma-Aldrich) as a substrate. Experiments were carried out at least three times with similar results to those shown. Samples incubated in dim room light (0.25 μW) gave results indistinguishable from samples incubated in total darkness. In constrast, bright room light (34 μW) activated reporters ~30% as well as blue LED-treated samples.
Live-cell imaging. Live-cell imaging was performed on a custom built spinning disc confocal microscope with a Yokogawa CSU10 scan head mounted on a Nikon TE300 inverted stand as previously described 13 . Images were acquired using a 60× Plan Apochromat 1.4 numerical aperture (NA) objective. A 1.5× tube lens between the filter wheel and camera focused light on the chip of a Hamamatsu C9100 electron-multiplying charge-coupled device (EM-CCD) camera giving a pixel size of 86 × 86 nm. The focal plane was controlled by a piezo-driven z-stage (Applied Scientific Instruments). The EM-CCD camera, filter wheel, stage and accusto-optic tunable filter (AOTF) laser line switching were controlled by Metamorph software (Molecular Devices). An environmental chamber (In vivo Scientific) enclosing the microscope stand maintained the temperature at 37 °C. HEK293T cells were grown on glass coverslips (Deckgläser #1, 18 mm) and maintained in DMEM containing 10% FBS. Cells were transfected with Lipofectamine 2000 (Invitrogen) when 50-80% confluent according to the manufacturers' protocols and imaged 24 h after transfection.
Excitation was provided by solid-state 488-nm (Coherent) or 561-nm (Spectraphysics) lasers shuttered via an AOTF (Neos Technologies), with emission directed through a filter wheel (Applied Scientific Instrumentation) holding either band pass or long pass filters (Chroma). Power used for stimulation of translocation was equivalent to that used for imaging EGFP (25 μW measured 1 cm from the objective). Wavelengths tested for triggering translocation were consistent with the absorbance profile of cryptochrome, which responds to UVA light and blue light with a peak at 450 nm and weakly above 500 nm 14, 15 (405-nm illumination triggered interaction) but illumination at 561 nm did not. Illumination at 514 nm (which would be used with YFP for two-color imaging) triggered interaction at high intensity illumination but not at lower intensity (under 2 μW) ( Supplementary Fig. 4) .
Reports in plant literature suggest that light activation of cryptochromes may be reversed with green light 14, 16 , but we did not observe any effect of illumination with green light (514 or 540 nm) on the reversal time of the CRY2-CIBN interaction. We also tested the interaction of CIBN-mCh with CRY2-pmEGFP. Although these proteins expressed well, they did not show lightinduced interaction. It is possible that membrane association of CRY2 sterically hindered the association with CIB in this conformation, and adjustment of the linker length may remedy this.
Dose-dependent activation of transcription. pDBTrp-CRY2 and pGBKT7rec-CIB1 constructs, along with a plasmid from a galactose-inducible yeast overexpression library 17 expressing the protein Snl1 from a galactose-inducible promoter, were transformed together into strain PJ694-a and plated on SD -Trp, -Leu, -Ura plates. The triple-transformed yeast were grown overnight at 30 °C in synthetic medium then diluted to OD 600 of 0.1 and placed in the dark. After an initial 3 h growth period in the dark, yeast cells were exposed to pulses of blue light from a fluorescence microscope beam (Leica MZFLIII) equipped with a GFP filter (10 s in duration, 8 min apart, 1.7 mW). Cultures remained in the dark for 4 h after the initial light exposure, and then they were collected for immunoblotting. Yeast were lysed in 2% SDS by glass bead disruption (425-600 μm beads, Sigma), after which samples were boiled for 3 min, placed in 2× Laemmli sample buffer, boiled for 1 min, and centrifuged at 20,000g for 5 min. Equal amounts of total protein were run on a 12% SDS-PAGE gel and immunoblotted using standard procedures using a mouse anti-HA as primary antibody (Covance) and an IRDye 700CW goat anti-mouse IgG as secondary antibody (Li-COR). Proteins were visualized using an Odyssey infrared imaging system (Li-COR).
Light activation of split Cre recombinase. HEK293T cells were transfected with the Cre reporter construct and indicated constructs, and percentage Cre reporter recombination was measured 48 h after transfection. For 'light-treated' samples, blue-light pulses (2-s pulse delivered every 3 min, 450 nm, 4.5 mW) were administered by a custom LED array light source. For 24-h experiments, light was administered from 24 to 48 h after transfection. For pulse experiments, samples were exposed to pulsed light (15 min or 1 h) 24 h after transfection, then incubated in the dark until 48 h after transfection to allow reporter expression. Nontreated samples were kept in the dark for the duration. Samples were fixed in 4% paraformaldehyde and the ratio of cells expressing EGFP to cells expressing mCherry was calculated, based on the average counts from three wells. The results reported are the average and s.d. from three independent experiments. To calculate the fold activation, the ratio of the percent of cells activated in the light to the percent activated in the dark was calculated after the background was subtracted. For the trypan blue-stained cell counts described in Supplementary Table 1 , collected cell cultures were incubated with 0.4% trypan blue solution (Sigma) for 3 min, then the number of blue versus white cells was determined using a hemocytometer.
Two-photon microscopy. Two-photon microscopy was performed using a Zeiss LSM 710 confocal scanhead mounted on an Axio-observer microscope a with Chameleon II ultra laser source using a 20× 1.0 NA Apochromat objective (Zeiss). Infrared laser power was normalized by measuring the power at the sample using a FiedMaxII power meter (Coherent) tuned to the corresponding wavelength. All two-photon experiments were performed using equivalent power, unless otherwise stated. HEK293T cells expressing CRY2PHR-mCh and CIBN-pmEGFP were imaged using 561-nm excitation with emission collected through a bandpass filter set for 570-610 nm. We collected 10 images of CIBN-mCh before exposure with 800-1,000 nm excitation. Two-photon excitation was repeated every 25 images (acquired at 1 Hz) for the duration of the experiment. Translocation occurred in the range of 830-980 nm. After the time-series completion, the localization of CIBN-pmEGFP was determined by acquiring a single image with 488-nm exposure (~1.5 μs pixel dwell time for 1 s) with emission collected through a bandpass filter set for 500-550 nm.
Organotypic slice culture was carried out as previously described except that rat pups were used instead of mouse pups 18 . Briefly, hippocampi from postnatal day 5-6 rat pups were dissected and slices (350 μm) were prepared using a McIlwain tissue chopper and cultured on 0.4 μm millicell membrane inserts (Millipore). After 6 d in culture, slices were biolistically transfected with CIBN-pmEGFP and CRY2PHR-mCh constructs (Helios gene gun; Biorad). After biolistic transfection, slices were either maintained in darkness or photostimulated 3-4 d after transfection. After light stimulation, slices were immediately fixed in PBS containing 4% paraformaldehyde in PBS for 10-15 min on ice. The CRY2PHR-mCh signal was enhanced with rabbit polyclonal anti-RFP (MBL) before mounting the slices for imaging.
